Michael R Dougherty Idera Pharmaceuticals, Inc. (IDRA) insider trading activity

Michael R Dougherty is of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 375,155 shares of IDRA, which is worth approximately $1.13 Million. The most recent transaction as insider was on Jan 11, 2023, when has been sold 33,523 shares (Common Stock) at a price of $0.44 per share, resulting in proceeds of $14,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 375K

0% 3M change

0% 12M change

Total Value Held $1.13 Million

MICHAEL R DOUGHERTY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 11 2023	BUY Grant, award, or other acquisition	$14,750 $0.44 p/Share	33,523 Added 8.2%	375,155 Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	$21,651 $0.37 p/Share	58,516 Added 14.62%	341,632 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	$22,038 $0.44 p/Share	50,086 Added 15.03%	283,116 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	$22,224 $0.54 p/Share	41,155 Added 15.01%	233,030 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$21,867 $0.59 p/Share	37,062 Added 16.19%	191,875 Common Stock
Oct 04 2021	BUY Grant, award, or other acquisition	$21,866 $1.03 p/Share	21,229 Added 12.06%	154,813 Common Stock
Jun 01 2021	BUY Open market or private purchase	$101,150 $1.19 p/Share	85,000 Added 38.89%	133,584 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	$14,439 $1.32 p/Share	10,939 Added 18.38%	48,584 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	$14,130 $4.02 p/Share	3,515 Added 8.54%	37,645 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	$12,874 $2.25 p/Share	5,722 Added 14.36%	34,130 Common Stock

Also insider at

MRNS

MARINUS PHARMACEUTICALS, INC. Healthcare

Director

TRVN

TREVENA INC Healthcare

Director

MRD